Cargando…

Psychotropic medication utilisation in adult cancer patients in China: A cross-sectional study based on national health insurance database

BACKGROUND: Psychotropic medications are useful to treat psychiatric disorders which are frequently underdiagnosed and undertreated in cancer patients. Evidence on utilisation of psychotropic medications in cancer patients was absent in China. This study aimed to analyse the prevalence and the poten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Lin, Xu, Ziyue, Huang, Cong, Sui, Yunchuan, Guan, Xiaodong, Shi, Luwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315446/ https://www.ncbi.nlm.nih.gov/pubmed/34327398 http://dx.doi.org/10.1016/j.lanwpc.2020.100060

Ejemplares similares

Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance Database
por: Zhang, Jingyuan, et al.
Publicado: (2019)

Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
por: Bai, Lin, et al.
Publicado: (2020)

Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015
por: Zhang, Jingyuan, et al.
Publicado: (2019)

Trends in the utilization of psychotropic medications in China from 2018 to 2021
por: Zhang, Xinyan, et al.
Publicado: (2022)

The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China
por: Guo, Zhigang, et al.
Publicado: (2017)

Medical insurance and healthcare utilization among the middle-aged and elderly in China: evidence from the China health and retirement longitudinal study 2011, 2013 and 2015
por: Zhou, Yue, et al.
Publicado: (2020)

The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data
por: Yang, Yu, et al.
Publicado: (2023)

Socioeconomic determinants of psychotropic drug utilisation among elderly: a national population-based cross-sectional study
por: Lesén, Eva, et al.
Publicado: (2010)

Secular trend analysis of antibiotic utilisation in China’s hospitals 2011–2018, a retrospective analysis of procurement data
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom
por: Ng, Vanessa W.S., et al.
Publicado: (2021)

Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases
por: Liu, Yihao, et al.
Publicado: (2020)

Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis
por: Wu, Min, et al.
Publicado: (2015)

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
por: Huang, Tao, et al.
Publicado: (2021)

A rapid appraisal of access to and utilisation of psychotropic medicines in Bihar, India
por: Padmanathan, Prianka, et al.
Publicado: (2014)

Effect of medical insurance and family financial risk on healthcare utilisation by patients with chronic diseases in China: a cross-sectional study
por: Shu, Zhan, et al.
Publicado: (2019)

Utilisation of health services among urban patients who had an ischaemic stroke with different health insurance - a cross-sectional study in China
por: Yang, Yong, et al.
Publicado: (2020)

Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data
por: Acquaviva, Eric, et al.
Publicado: (2009)

Effects of the Full Coverage Policy of Essential Medicines on Inequality in Medication Adherence: A Longitudinal Study in Taizhou, China
por: Guo, Zhigang, et al.
Publicado: (2022)

National Prescribing Patterns of Psychotropic Medications in Older Adults in Oman
por: Al-Shehhi, Afaf, et al.
Publicado: (2023)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

Trends in Psychotropic Medication Prescriptions in Urban China From 2013 to 2017: National Population-Based Study
por: Xu, Lu, et al.
Publicado: (2021)

Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis
por: Huang, Cong, et al.
Publicado: (2021)

Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020
por: Zhang, Yichen, et al.
Publicado: (2022)

Sales trends of psychotropic drugs in the COVID-19 pandemic: A national database study in Brazil
por: Del Fiol, Fernando de Sá, et al.
Publicado: (2023)

Effect of the full coverage policy of essential medicines on medication adherence: A quasi-experimental study in Taizhou, China
por: Guo, Zhigang, et al.
Publicado: (2022)

Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China
por: Huang, Tao, et al.
Publicado: (2022)

The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China
por: Zhang, Yichen, et al.
Publicado: (2021)

The Effect of Urban Basic Medical Insurance on Health Service Utilisation in Shaanxi Province, China: A Comparison of Two Schemes
por: Zhou, Zhongliang, et al.
Publicado: (2014)

The effects of China’s urban basic medical insurance schemes on the equity of health service utilisation: evidence from Shaanxi Province
por: Zhou, Zhongliang, et al.
Publicado: (2014)

Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015–2019 in Guangdong, China
por: Zhan, Chunwang, et al.
Publicado: (2022)

Drug-drug Interaction between Psychotropic Medications and Medications Used in COVID-19: Comparison of Online Databases
por: Chatterjee, Surobhi, et al.
Publicado: (2023)

National Health Insurance Databases in Indonesia, Vietnam and the Philippines
por: Ng, Junice Yi Siu, et al.
Publicado: (2019)

National health insurance subscription and maternal healthcare utilisation across mothers’ wealth status in Ghana
por: Ameyaw, Edward Kwabena, et al.
Publicado: (2017)

Acid Suppression Use Among Infants in One Tertiary Children's Hospital in China, 2015–2018: A Retrospective Observational Study
por: Zhou, Yue, et al.
Publicado: (2021)

Impact of the National Health Insurance Coverage Policy on the Utilisation and Accessibility of Innovative Anti-cancer Medicines in China: An Interrupted Time-Series Study
por: Fang, Wenqing, et al.
Publicado: (2021)

The National Insurance Medical Association
Publicado: (1912)

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
por: Huang, Cong, et al.
Publicado: (2022)

Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis
por: Wei, Guoxu, et al.
Publicado: (2021)

National trends in psychotropic medication prescribing before and during the COVID-19 pandemic()
por: Sanborn, Molly, et al.
Publicado: (2023)

Women empowerment and health insurance utilisation in Rwanda: a nationwide cross-sectional survey
por: Kawuki, Joseph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_54eami48efhf7dmdb07e0ueljr